Here are relevant reports on : breast-implants-market
-
Digital Biomarkers Market by Type (Physiological, Vocal, Idiosyncratic), Therapy [Cardio, Onco (Lung, Breast Cancer), Mental Health, Neuro], Application [Clinical Research (Phase IV)], End User (Pharma & Biotech Companies, CROs) – Global Forecast to 2031
The global digital biomarkers market is projected to reach USD 17.73 billion by 2031, growing at a CAGR of 19.1% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Plastic Surgery Instruments Market by Type (Handheld (Forceps, Needle Holder, Scissors, Retractor), Electrosurgery (Bipolar, Monopolar)), Procedure (Cosmetic (Breast Augmentation, Face, Head, Extremities), Reconstructive), End User - Global Forecast to 2023
The global plastic surgery instruments market is projected to reach USD 1,479.0 Million by 2023, growing at a CAGR of 8.1%. Prominent players in the plastic surgery instruments market include Sklar Surgical Instruments (US), KLS Martin Group (Germany), Integra LifeSciences Corporation (US), Tekno-Medical Optik-Chirurgie GmbH (Germany), KARL STORZ GmbH & Co. KG (Germany), Zimmer Biomet (US), B. Braun Melsungen AG (Germany), BMT Medizintechnik GmbH (Germany), Anthony Products, Inc. (US), Bolton Surgical Ltd. (UK), Surgicon Pvt. Ltd. (Pakistan), and Blink Medical (UK).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Immuno Oncology Assays Market Size, Share & Trends by Product & Service (Consumables, Instruments, Software), Technology (PCR, NGS, Immunoassay), Cancer Indications (Lung, Breast, Colorectal, Bladder, Melanoma), Application (Research, Diagnostics) - Global Forecast to 2026
The size of global immuno oncology assays market in terms of revenue was estimated to be worth USD 4.4 billion in 2021 and is poised to reach USD 7.9 billion by 2026, growing at a CAGR of 12.5% from 2021 to 2026. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: April 2021
- Price: $ 4950
- TOC Available:
-
Cancer Supportive Care Drugs Market by Drug Class (G-CSFS, ESAS, Antiemetics, Bisphosphonates, Opioids, Nsaids), Cancer Type (Breast Cancer, Lung Cancer, Melanoma, Prostate Cancer, Other Cancers) - Global Forecast to 2023
Cancer supportive care also known as palliative care is focused on relieving patients from side effects of cancer therapies. In cancer palliative care, supportive drugs are used to lessen the side effects of cancer treatments. In many cases cancer treatments need to be stopped or doses need to lowered due various reasons such as low blood cell counts. In such cases, cancer supportive drugs such as CSFs enable patients to continue with cancer treatments as well as in other cases, it also allows higher doses of cancer therapies. Cancer being one of the leading causes of death worldwide, there has been increasing focus on cancer treatments. Many cancer treatments comes with various side effects such as fatigue, pain, fertility problems, depression, heartburn, sexual problems, bone diseases and other side effects. With such side effects, there is preference to use supportive care drugs during cancer treatments. Such factors are expected to drive the cancer supportive care drugs market. However, there are some side effects associated with cancer supportive care drugs which may hinder the market growth.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Noninvasive Cancer Diagnostics Market by Instruments (Solid Tumor, Blood Cancer, Lung Cancer, Breast Cancer), Technology (Clinical Chemistry, Immunochemistry, Molecular Diagnostics) - Analysis & Global Forecast to 2019
The global non-invasive cancer diagnostic market is expected to show considerable growth during the forecast period. This is attributed to growing cancer cases worldwide, especially breast and lung cancer. In 2013, in the U.S. there were more than 1,660,290 new cases of all type of cancers diagnosed in 2013 (American Cancer Society). Increased healthcare expenditure and increase research and development activities are some of the other factors driving the growth of this market. However factors such as high cost of treatment, and stringent regulatory guidelines are limiting the market growth.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
European Mammography Workstations Market by Modality (Multimodal, Standalone), Application (Diagnosis, Advanced Imaging, Clinical Review), End User (Hospital, Breast Care Centers, Academia), Country (Germany, UK, France, Italy, Spain) - Forecast to 2024
The European mammography workstations market is estimated to grow at a CAGR of 5.5% to reach USD 14 million by 2024 from USD 10 million in 2018. Factors such as the rising burden of breast cancer, increasing market availability of multimodality diagnostic platforms, and the increasing patient awareness about the clinical benefits associated with the early diagnosis of breast conditions are driving the growth of the European mammography workstations market.General Electric (US), Koninklijke Philips N.V. (Netherlands), Hologic Inc. (US), Siemens (Germany), and FUJIFILM Corporation (Japan) are the major players in the European mammography workstations market. Other prominent players in this market include Carestream Health (US), EIZO Corporation (Japan), Agfa-Gevaert Group (Belgium), Barco (Belgium), Konica Minolta, Inc. (Japan), Benetec Advanced Medical Systems (Belgium), PLANMED OY (Finland), Sectra AB (Sweden), Aycan Medical Systems, LLC. (US), and Esaote SPA (Italy).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Robotic Radiotherapy Market Size by Product (System, Software, 3D Camera), Technology (LINAC, Stereotactic, Particle Therapy), Application (Lung, Breast, Colorectal), End-User (Hospitals, Radiotherapy Centres), & Region - Global Forecast to 2028
The global robotic radiotherapy market, valued at US$0.8 billion in 2021, stood at US$1.1 billion in 2023 and is projected to advance at a resilient CAGR of 11.9% from 2023 to 2028, culminating in a forecasted valuation of US$1.9 billion by the end of the period. The market's expansion is driven by several factors, including the global rise in cancer cases, advancements in automation technologies enhancing the precision of radiotherapy, a growing preference for non-invasive cancer treatments, and the rapid proliferation of cancer treatment facilities.
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Medical Packaging Market by Material (Polymer, Non-woven Fabric, Paper & Paperboard), Packaging Type (Bags & Pouches, Trays, Boxes), Application (Medical Equipment & Tools, Medical Devices, Implants, IVDs), Packing Type, and Region - Forecast to 2022
The market for medical packaging is projected to grow from USD 35.31 Billion in 2016 to USD 50.55 Billion by 2022, at a compound annual growth rate (CAGR) of 6.29% from 2017 to 2022. The base year considered for the study is 2016 and the market size is projected from 2017 to 2022. The global market for medical packaging is dominated by large players such as Avery Dennison Corporation (U.S.), 3M Company (U.S.), E. I. du Pont de Nemours and Company (U.S.), CCL Industries, Inc. (Canada) , Amcor Limited (Australia), Constantia Flexibles Group GmbH (Austria), Bemis Company (U.S.) , Sonoco Products Company (U.S.) , WestRock Company (U.S.). These players have adopted various strategies to expand their global presence and increase their market share. Mergers & acquisitions, expansions, and new product launches are some of the major strategies adopted by market players to achieve growth in the medical packaging market.
- Published: July 2017
- Price: $ 4950
- TOC Available:
-
Remote Patient Monitoring (RPM) Market by Offering [Software, Device (Wearable, Implants, Handheld)], Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End User (Hospital, ASC, Pharma & Biotech) - Global Forecast to 2031
The global remote patient monitoring market is projected to reach USD 66.33 billion by 2031, growing at a CAGR of 12.8% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Orthopedics Market by Product (Orthopedic Implants, Instruments, Consumables), Animal Type (Dog, Cat, Horse, Livestock), Application (TPLO, TTA, Fracture Repair), Material (Metallic, Absorbable), End User, and Region - Global Forecast to 2031
The veterinary orthopedics market is projected to reach USD 0.86 billion by 2031 from USD 0.57 billion in 2026, at a CAGR of 8.5% from 2026 to 2031. Market is driven by factors such as growth in companion animal population, growing demand for pet insurance, and rising expenditure on animal healthcare. On the other hand, high cost of veterinary orthopedic devices and procedure is expected to restrain market growth to a some extent during the forecast period.
- Published: January 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
